VASH1 and diabetic kidney disease: The increased levels of VEGF-A in the diabetic VASH1+/− mice as well as VASH1 siRNA-transfected mouse podocytes may be associated with the deterioration of diabetic nephropathy, consistent with previous reports [13], [14].